SCHEMBL31547501

SCHEMBL31547501

COc1nc(C2CCOCC2)ccc1C(=O)N[C@@H]1C=CS(=O)(=O)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
JAK2 O60674 1/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 3/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
CNR2 P34972 1/20 0.34
MAPK1 P28482 2/20 0.33
POLB P06746 1/20 0.33
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
PDE4B Q07343 3/20 0.32
HPGDS O60760 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30364997 0.90 LMNA (0.44) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30364650 0.87 LMNA (0.43) LMNAMEN1KMT2AJAK2TP53
SCHEMBL25149343 0.86 LMNA (0.41) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30365185 0.86 LMNA (0.41) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30365013 0.85 LMNA (0.40) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30364609 0.81 LMNA (0.41) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30364621 0.80 LMNA (0.48) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30365111 0.80 LMNA (0.48) LMNAMEN1KMT2AJAK2TP53
SCHEMBL30364760 0.79 LMNA (0.44) LMNAMEN1KMT2AJAK2TP53
SCHEMBL25149477 0.78 BRD4 (0.39) LMNAMEN1KMT2AJAK2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025073792-A1 WRN INHIBITORY COMPOUNDS FORX THERAPEUTICS AG (CH) 2025-04-10 WO claimed
WO-2025073792-A1 WRN INHIBITORY COMPOUNDS FORX THERAPEUTICS AG (CH) 2025-04-10 WO disclosed